Clinical Trial Update: B/F/TAF Switch Study for HIV-HBV Coinfection [Phase 4]

View source ↗

Summary

Phase 4 trial update on switching to B/F/TAF for HIV-HBV coinfection; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B

Drugs mentioned

• B/F/TAF (emtricitabine/tenofovir alafenamide/cobicistat-darunavir)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: HIV-1-infection, Hepatitis B | Phase 4 | Status: COMPLETED | Results posted: 2023-07-18